Summary

Rapid Tests Market Summary

The global rapid tests market size was estimated at USD 1.69 billion in 2025 and is projected to reach USD 3.25 billion by 2033, growing at a CAGR of 8.30% from 2026 to 2033. The growth can be attributed to the growing geriatric population, rising target disease burden, and increasing adoption of self-testing & point-of-care products.

Upper respiratory tract infections (URIs) remain extremely common worldwide, with incidence rates exceeding 162,000 per 100,000 people in recent global estimates, underscoring the need for rapid differentiation of viral versus bacterial causes in clinical practice.

Upper respiratory tract infections (URTIs) remain a major global health concern in 2025, with high incidence rates particularly in children under 5 and adults with underlying conditions. Children under 5 are the most affected group for URTIs, while 97% of pediatric RSV deaths occur in low- and middle-income countries.

Furthermore, Respiratory syncytial virus (RSV) is a highly prevalent viral infection that particularly affects infants, young children, and older adults. Globally, RSV is estimated to cause approximately 33 million acute lower respiratory tract infections annually in children under five years, with over 3 million cases requiring hospitalization. In the U.S., RSV leads to 58,000-80,000 hospitalizations and 100-300 deaths among children under five each year, as well as 60,000-160,000 hospitalizations and 6,000-10,000 deaths among adults aged 65 and older. Seasonal outbreaks typically occur in the fall and winter, significantly impacting healthcare systems and underscoring the critical need for effective diagnostic and preventive measures.

Below is a comparison of Virus detections by subtype reported to FluNet, 01 October 2017 to 30 December 2024, from countries in the Northern hemisphere, as of 07 January 2025:

The dataset plots estimated global volumes of rapid diagnostics that correspond with observed respiratory pathogen activity:

Influenza rapid test demand accounts for the largest share of total respiratory testing due to its high seasonal prevalence and broad availability of RIDTs. This results in high growth of the rapid influenza diagnostic tests market over the forecast years.

RSV rapid test demand is significant and growing, driven by pediatric and high-risk population screening.

hMPV contributes a smaller but meaningful share, especially where multiplex testing platforms incorporate hMPV targets.

Collectively, these drivers reflect how seasonal respiratory trends translate into diagnostic demand, highlighting the seasonality and pathogen-specific test utilization that underpins market expansion.

Across infectious disease surveillance and public health programs, rapid tests are increasingly playing a strategic role. Governments and health authorities in 2025 are scaling up access to rapid diagnostic kits for endemic conditions beyond COVID-19; for example, the Indian Council of Medical Research (ICMR) has advocated rapid test availability for conditions such as Hepatitis B, sickle cell anemia, and syphilis at primary health centres, aiming to improve early diagnosis in underserved areas. Meanwhile, markets for specific rapid tests, such as rapid influenza diagnostic tests (RIDTs), are projected to grow steadily as seasonal flu and respiratory illnesses persist globally. This widening scope of disease targets is expanding the application base of rapid diagnostics beyond upper respiratory infections and sepsis screening into the arenas of infectious and non-communicable diseases.

Innovation and competitive dynamics are reshaping the competitive landscape and product development trajectory. Providers are increasingly integrating advanced technologies such as AI, machine learning, and microfluidics to enhance test sensitivity, multiplexing, and ease of use, which supports broader adoption in both clinical and at-home settings. Established diagnostic players and new entrants are also influencing market growth paths: for instance, Amazon’s entry into home diagnostics services across major Indian cities in mid-2025 triggered notable shifts in investor sentiment in the diagnostics sector. At the same time, large strategic moves like Abbott’s planned acquisition of Exact Sciences?makers of widely used cancer and genetic tests signal diagnostic companies’ push to diversify beyond traditional rapid infectious disease testing into broader screening portfolios, even as they balance quality assurance and regulatory challenges in an increasingly crowded market.

Furthermore, the introduction of mobile applications, such as cobas infinity point-of-care from Roche Diagnostics, to satisfy the requirements of the POC coordinator and aid in enhancing productivity by completing the task on the smartphone irrespective of the destination, can be expected to drive the adoption of POC molecular diagnostic products during the forecast period.

Key players have shifted their focus to commercializing home-based self-testing products in recent years, and the COVID-19 outbreak has propelled this trend. Amid government-imposed lockdowns, such products addressed clinical needs while promoting self-quarantine practices. Companies, such as Abbott, have products like BinaxNOW Card rapid test for influenza and COVID-19 that delivers results at home in 15 minutes. This product comes with a virtual guide and application to enable the testing process and display test results.

Global Rapid Tests Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 - 2033. For this report, Grand View Research has segmented the global rapid tests market report based on the product, technology, application, end use, and region.

? Product Outlook (Revenue, USD Million, 2021 - 2033)
? Instruments
? Consumables
? Others
? Technology Outlook (Revenue, USD Million, 2021 - 2033)
? Immunoassay
? Molecular Diagnostics
? Other technologies
? Application Outlook (Revenue, USD Million, 2021 - 2033)
? Upper respiratory tract infections
o Influenza and Parainfluenza virus
o Streptococcus
o Respiratory syncytial virus
? Antibiotic resistant infections
? Sepsis
o Bacterial Sepsis
o Fungal Sepsis
o Others
? End Use Outlook (Revenue, USD Million, 2021 - 2033)
? Hospitals & Clinics
? Laboratories
? At-home testing and Others
? Regional Outlook (Revenue, USD Million, 2021 - 2033)
? North America
o U.S.
o Canada
o Mexico
? Europe
o Germany
o UK
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
? Asia Pacific
o Japan
o China
o India
o Australia
o South Korea
o Thailand
? Latin America
o Brazil
o Argentina
? Middle East and Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Market Definitions
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Type and Product Snapshot
2.3. Application and End Use Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Increasing Adoption of Self-Testing & Point-of-Care Products, And Introduction of CLIA Waived Tests
3.3.1.2. Growing Geriatric Population Base
3.3.1.3. Introduction of Advance Technology Enablx Ed Products
3.3.1.4. Growing Prevalence of Target Diseases
3.3.2. Market Restraint Analysis
3.3.2.1. Presence of Ambiguous Regulatory and Reimbursement Framework for Primary Care Setting
3.3.2.2. Rapid Testing Sensitivity and Accuracy
3.4. Business Environment Analysis
3.4.1. PESTLE Analysis
3.4.2. Porter’s Five Forces Analysis
3.5. COVID-19 Impact Analysis
Chapter 4. Technology Business Analysis
4.1. Rapid Tests Market: Technology Movement Analysis, 2025 & 2033
4.2. Molecular Diagnostics
4.2.1. Molecular Diagnostics Market, 2021 - 2033 (USD Million)
4.3. Immunoassay
4.3.1. Immunoassay Market, 2021 - 2033 (USD Million)
4.4. Others
4.4.1. Others Market, 2021 - 2033 (USD Million)
Chapter 5. Product Business Analysis
5.1. Rapid Tests Market: Product Movement Analysis, 2025 & 2033
5.2. Instruments
5.2.1. Instruments Market, 2021 - 2033 (USD Million)
5.3. Consumables
5.3.1. Consumables Market, 2021 - 2033 (USD Million)
5.4. Others
5.4.1. Others Market, 2021 - 2033 (USD Million)
Chapter 6. Application Business Analysis
6.1. Rapid Tests Market: Application Movement Analysis, 2025 & 2033
6.2. Upper Respiratory Tract Infections
6.2.1. Upper Respiratory Tract Infections Market, 2021 - 2033 (USD Million)
6.2.2. Influenza And Parainfluenza Virus
6.2.2.1. Influenza And Parainfluenza Virus Market, 2021 - 2033 (USD Million)
6.2.3. Respiratory Syncytial Virus
6.2.3.1. Respiratory Syncytial Virus Market, 2021 - 2033 (USD Million)
6.2.4. Streptococcus
6.2.4.1. Streptococcus Market, 2021 - 2033 (USD Million)
6.3. Antibiotic-Resistant Infections (MRSA, Streptococcus Pneumonia, And Others)
6.3.1. Antibiotic-Resistant Infections (MRSA, Streptococcus Pneumoniae, And Others) Market, 2021 - 2033 (USD Million)
6.4. Sepsis
6.4.1. Sepsis Market, 2021 - 2033 (USD Million)
6.4.2. Bacterial Sepsis
6.4.2.1. Bacterial Sepsis Market, 2021 - 2033 (USD Million)
6.4.3. Fungal Sepsis
6.4.3.1. Fungal Sepsis Market, 2021 - 2033 (USD Million)
6.4.4. Others
6.4.4.1. Others Market, 2021 - 2033 (USD Million)
Chapter 7. End Use Business Analysis
7.1. Rapid Tests Market: End Use Movement Analysis, 2025 & 2033
7.2. Hospitals & Clinics
7.2.1. Hospitals & Clinics Market, 2021 ? 2033 (USD Million)
7.3. Laboratories
7.3.1. Laboratories Market, 2021 ? 2033 (USD Million)
7.4. At-Home Testing And Others
7.4.1. At-Home Testing And Others Market, 2021 ? 2033 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Regional Market Snapshot
8.2. North America
8.2.1. North America Rapid Tests Market, 2021 - 2033 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Rapid Tests Market, 2021 - 2033 (USD Million)
8.2.2.2. Key Country Dynamics
8.2.2.3. Regulatory Framework
8.2.2.4. Competitive Scenario
8.2.3. Canada
8.2.3.1. Canada Rapid Tests Market, 2021 - 2033 (USD Million)
8.2.3.2. Key Country Dynamics
8.2.3.3. Regulatory Framework
8.2.3.4. Competitive Scenario
8.2.4. Mexico
8.2.4.1. Mexico Rapid Tests Market, 2021 - 2033 (USD Million)
8.2.4.2. Key Country Dynamics
8.2.4.3. Regulatory Framework
8.2.4.4. Competitive Scenario
8.3. Europe
8.3.1. Europe Rapid Tests Market, 2021 - 2033 (USD Million)
8.3.2. Germany
8.3.2.1. Germany Rapid Tests Market, 2021 - 2033 (USD Million)
8.3.2.2. Key Country Dynamics
8.3.2.3. Regulatory Framework
8.3.2.4. Competitive Scenario
8.3.3. UK
8.3.3.1. UK Rapid Tests Market, 2021 - 2033 (USD Million)
8.3.3.2. Key Country Dynamics
8.3.3.3. Regulatory Framework
8.3.3.4. Competitive Scenario
8.3.4. France
8.3.4.1. France Rapid Tests Market, 2021 - 2033 (USD Million)
8.3.4.2. Key Country Dynamics
8.3.4.3. Regulatory Framework
8.3.4.4. Competitive Scenario
8.3.5. Italy
8.3.5.1. Italy Rapid Tests Market, 2021 - 2033 (USD Million)
8.3.5.2. Key Country Dynamics
8.3.5.3. Regulatory Framework
8.3.5.4. Competitive Scenario
8.3.6. Spain
8.3.6.1. Spain Rapid Tests Market, 2021 - 2033 (USD Million)
8.3.6.2. Key Country Dynamics
8.3.6.3. Regulatory Framework
8.3.6.4. Competitive Scenario
8.3.7. Denmark
8.3.7.1. Denmark Rapid Tests Market, 2021 - 2033 (USD Million)
8.3.7.2. Key Country Dynamics
8.3.7.3. Regulatory Framework
8.3.7.4. Competitive Scenario
8.3.8. Sweden
8.3.8.1. Sweden Rapid Tests Market, 2021 - 2033 (USD Million)
8.3.8.2. Key Country Dynamics
8.3.8.3. Regulatory Framework
8.3.8.4. Competitive Scenario
8.3.9. Norway
8.3.9.1. Norway Rapid Tests Market, 2021 - 2033 (USD Million)
8.3.9.2. Key Country Dynamics
8.3.9.3. Regulatory Framework
8.3.9.4. Competitive Scenario
8.4. Asia Pacific
8.4.1. Asia Pacific Rapid Tests Market, 2021 - 2033 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Rapid Tests Market, 2021 - 2033 (USD Million)
8.4.2.2. Key Country Dynamics
8.4.2.3. Regulatory Framework
8.4.2.4. Competitive Scenario
8.4.3. China
8.4.3.1. China Rapid Tests Market, 2021 - 2033 (USD Million)
8.4.3.2. Key Country Dynamics
8.4.3.3. Regulatory Framework
8.4.3.4. Competitive Scenario
8.4.4. India
8.4.4.1. India Rapid Tests Market, 2021 - 2033 (USD Million)
8.4.4.2. Key Country Dynamics
8.4.4.3. Regulatory Framework
8.4.4.4. Competitive Scenario
8.4.5. South Korea
8.4.5.1. South Korea Rapid Tests Market, 2021 - 2033 (USD Million)
8.4.5.2. Key Country Dynamics
8.4.5.3. Regulatory Framework
8.4.5.4. Competitive Scenario
8.4.6. Australia
8.4.6.1. Australia Rapid Tests Market, 2021 - 2033 (USD Million)
8.4.6.2. Key Country Dynamics
8.4.6.3. Regulatory Framework
8.4.6.4. Competitive Scenario
8.4.7. Thailand
8.4.7.1. Thailand Rapid Tests Market, 2021 - 2033 (USD Million)
8.4.7.2. Key Country Dynamics
8.4.7.3. Regulatory Framework
8.4.7.4. Competitive Scenario
8.5. Latin America
8.5.1. Latin America Rapid Tests Market, 2021 - 2033 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Rapid Tests Market, 2021 - 2033 (USD Million)
8.5.2.2. Key Country Dynamics
8.5.2.3. Regulatory Framework
8.5.2.4. Competitive Scenario
8.5.3. Argentina
8.5.3.1. Argentina Rapid Tests Market, 2021 - 2033 (USD Million)
8.5.3.2. Key Country Dynamics
8.5.3.3. Regulatory Framework
8.5.3.4. Competitive Scenario
8.6. MEA
8.6.1. MEA Rapid Tests Market, 2021 - 2033 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Rapid Tests Market, 2021 - 2033 (USD Million)
8.6.2.2. Key Country Dynamics
8.6.2.3. Regulatory Framework
8.6.2.4. Competitive Scenario
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Rapid Tests Market, 2021 - 2033 (USD Million)
8.6.3.2. Key Country Dynamics
8.6.3.3. Regulatory Framework
8.6.3.4. Competitive Scenario
8.6.4. UAE
8.6.4.1. UAE Rapid Tests Market, 2021 - 2033 (USD Million)
8.6.4.2. Key Country Dynamics
8.6.4.3. Regulatory Framework
8.6.4.4. Competitive Scenario
8.6.5. Kuwait
8.6.5.1. Kuwait Rapid Tests Market, 2021 - 2033 (USD Million)
8.6.5.2. Key Country Dynamics
8.6.5.3. Regulatory Framework
8.6.5.4. Competitive Scenario
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1. Acquisition
9.2.2. Collaborations
9.2.3. New Platform Launches
9.2.4. Others
9.3. Company Profiles/Listing
9.3.1. BD (Becton, Dickinson and Company)
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Diasorin S.P.A
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Abbott
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Danaher Corporation
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Thermo Fisher Scientific Inc
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Biom?rieux SA
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. F. Hoffmann-La Roche Ltd.
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives

ページTOPに戻る

List of Tables/Graphs

List of Tables

Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 Global Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 4 Global Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 5 Global Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 6 Global Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 7 Global Rapid Tests Market, By Region, 2021 - 2033 (USD Million)
Table 8 North America Rapid Tests Market, By Country, 2021 - 2033 (USD Million)
Table 9 North America Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 10 North America Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 11 North America Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 12 North America OTC US Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 13 U.S. Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 14 U.S. Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 15 U.S. Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 16 U.S. Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 17 Canada Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 18 Canada Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 19 Canada Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 20 Canada Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 21 Mexico Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 22 Mexico Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 23 Mexico Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 24 Mexico Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 25 Europe Rapid Tests Market, By Country, 2021 - 2033 (USD Million)
Table 26 Europe Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 27 Europe Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 28 Europe Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 29 Europe Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 30 UK Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 31 UK Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 32 UK Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 33 UK Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 34 Germany Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 35 Germany Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 36 Germany Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 37 Germany Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 38 France Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 39 France Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 40 France Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 41 France Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 42 Italy Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 43 Italy Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 44 Italy Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 45 Italy Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 46 Spain Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 47 Spain Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 48 Spain Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 49 Spain Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 50 Norway Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 51 Norway Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 52 Norway Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 53 Norway Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 54 Sweden Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 55 Sweden Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 56 Sweden Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 57 Sweden Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 58 Denmark Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 59 Denmark Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 60 Denmark Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 61 Denmark Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 62 Asia Pacific Rapid Tests Market, By Country, 2021 - 2033 (USD Million)
Table 63 Asia Pacific Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 64 Asia Pacific Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 65 Asia Pacific Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 66 Asia Pacific Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 67 Japan Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 68 Japan Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 69 Japan Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 70 Japan Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 71 China Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 72 China Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 73 China Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 74 China Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 75 India Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 76 India Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 77 India Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 78 India Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 79 Australia Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 80 Australia Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 81 Australia Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 82 Australia Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 83 South Korea Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 84 South Korea Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 85 South Korea Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 86 South Korea Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 87 Thailand Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 88 Thailand Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 89 Thailand Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 90 Thailand Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 91 Latin America Rapid Tests Market, By Country, 2021 - 2033 (USD Million)
Table 92 Latin America Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 93 Latin America Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 94 Latin America Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 95 Latin America Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 96 Brazil Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 97 Brazil Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 98 Brazil Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 99 Brazil Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 100 Argentina Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 101 Argentina Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 102 Argentina Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 103 Argentina Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 104 Middle East Africa Rapid Tests Market, By Country, 2021 - 2033 (USD Million)
Table 105 Middle East Africa Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 106 Middle East Africa Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 107 Middle East Africa Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 108 Middle East Africa Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 109 South Africa Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 110 South Africa Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 111 South Africa Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 112 South Africa Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 113 Saudi Arabia Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 114 Saudi Arabia Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 115 Saudi Arabia Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 116 Saudi Arabia Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 117 UAE Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 118 UAE Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 119 UAE Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 120 UAE Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
Table 121 Kuwait Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
Table 122 Kuwait Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
Table 123 Kuwait Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
Table 124 Kuwait Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)List of Figures

Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Market Segmentation
Fig. 8 Market Snapshot, 2025
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Market Penetration & Growth Prospect Mapping, 2025
Fig. 15 Global Rapid Tests Market: Type Movement Analysis
Fig. 16 Instruments market, 2021 - 2033 (USD Million)
Fig. 17 Consumables market, 2021 - 2033 (USD Million)
Fig. 18 Others market, 2021 - 2033 (USD Million)
Fig. 19 Rapid testing technology outlook: Key takeaways
Fig. 20 Rapid testing market: Technology movement analysis (USD Million)
Fig. 21 Molecular diagnostics market, 2021 - 2033 (USD Million)
Fig. 22 Immunoassay market, 2021 - 2033 (USD Million)
Fig. 23 Others market, 2021 - 2033 (USD Million)
Fig. 24 Rapid testing application outlook: Key takeaways
Fig. 25 Rapid testing market: Application type movement analysis (USD Million)
Fig. 26 Upper respiratory tract infections market, 2021 - 2033 (USD Million)
Fig. 27 Influenza and parainfluenza virus market, 2021 - 2033 (USD Million)
Fig. 28 Respiratory syncytial virus market, 2021 - 2033 (USD Million)
Fig. 29 Streptococcus market, 2021 - 2033 (USD Million)
Fig. 30 Antibiotic-resistant infections (MRSA, Streptococcus pneumonia, and others) market, 2021 - 2033 (USD Million)
Fig. 31 Sepsis market, 2021 - 2033 (USD Million)
Fig. 32 Bacterial Sepsis market, 2021 - 2033 (USD Million)
Fig. 33 Fungal sepsis market, 2021 - 2033 (USD Million)
Fig. 34 Others market, 2021 - 2033 (USD Million)
Fig. 35 Rapid testing End Use outlook: Key takeaways
Fig. 36 Rapid testing market: End Use movement analysis (USD Million)
Fig. 37 Hospitals & clinics market, 2021 - 2033 (USD Million)
Fig. 38 Laboratories market, 2021 - 2033 (USD Million)
Fig. 39 At-home testing and others market, 2021 - 2033 (USD Million)
Fig. 40 Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 41 Regional Marketplace: Key Takeaways
Fig. 42 Regional Outlook, 2025 & 2033
Fig. 43 Global Rapid Tests Market: Regional Movement Analysis
Fig. 44 North America Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 45 US Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 46 Canada Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 47 Mexico Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 48 Europe Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 49 Germany Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 50 UK Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 51 France Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 52 Italy Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 53 Spain Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 54 Denmark Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 55 Sweden Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 56 Norway Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 57 Asia Pacific Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 58 Japan Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 59 China Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 60 India Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 61 Australia Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 62 South Korea Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 63 Thailand Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 64 Latin America Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 65 Brazil Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 66 Argentina Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 67 Middle East And Africa Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 68 South Africa Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 69 Saudi Arabia Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 70 UAE Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 71 Kuwait Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)